Equality, Development, Inclusion, and Transcultural perspectives (EDIT) Presidential Advisory Group to the WCP 2025 in Prague

Recognizing the evolving needs for inclusion of geographically diverse populations of different genders and ages, the WPA formed an Advisory Group dedicated to Equality, Development, Inclusion, and Transcultural perspectives (EDIT) to mirror, consequently, those perspectives in the congress’s symposia, debates, and individual oral and poster presentations.

The EDIT Presidential Advisory Group stands for:

▪ Equality across genders, ages and ethnicities;

▪ Development from childhood to adulthood and beyond;

▪ Inclusion of under-represented groups;

▪ Transcultural awareness and perspectives.

When and where applicable, this approach, will hopefully be a transformative step towards a more inclusive and culturally competent field of psychiatry, both in the content of presentations and among the presenters. It will also show research gaps and needs for further actions, the execution of which will reaffirm the WPA’s commitment to the well-being of all individuals and communities, irrespective of their backgrounds.

Each submission should state how their presentation covers (or not) Equality, Development, Inclusion and Transcultural perspectives.

Please read the submission rules before submitting an abstract.

• Abstracts must be submitted online via the website only.
  ABSTRACTS SUBMITTED BY EMAIL WILL NOT BE ACCEPTED.
• Presentation Type: Abstracts may be submitted for free communications or e-poster presentation.
  The Scientific Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.
• Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
• Limitations:
• The same person may submit up to 4 abstracts regardless of presenting author.
• The same person may serve as presenting author on up to 4 abstracts.
• Presenting authors must be registered participants. Only abstracts of authors who have paid their registration fees by 10 June 2025 will be scheduled for presentation and included for publication.
• Submission of an abstract acknowledges your acceptance for the abstract to be published in the official Congress publications.
• The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.
• Previously Presented/Published Policy:
  • Abstracts must be original and must not have been published or presented at any other prior meeting. If, however, the abstract to be presented is on a topic you have used before, but now have developed a new poster or presentation with a varied viewpoint (or focused on a different aspect of the research) then you are welcome to submit the abstract.
• Abstracts must be submitted in English.
• Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.
• Instructions for preparation of presentations will be made available on the congress website.

Before you begin, please prepare the following information:

• ​Presenting author’s contact details:
  -Full first and family name(s)
  – Email address
  – Affiliation details: department, institution / hospital, city, state (if relevant), country
  – Phone number
• Author and co-authors’ details
• Preferred Presentation type: Free Communications or E-Poster ​
• Abstract title – must be in UPPER CASE and limited to 25 words. Please submit symbols as words.
• Abstract text – limited to 250 words including acknowledgements. Please note: word count is affected when tables are included.

• Abstract topic– select the abstract topic per the list of topics.
• Images– The maximum file size of each image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. You may upload images in JPG, GIF or PNG format.
• Abstracts should clearly state:
  Background and aims
  Methods
  Results
  Conclusions
• Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
• Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
• Submissions may not contain patient names, hospital ID numbers or other identifying information.
• The submission form allows you to store your abstract as a DRAFT until the deadline. After the deadline if not submitted, drafts will be deleted.
• Click on the SUBMIT button at the end of the process in order to submit your abstract. Changes will not be possible to your abstract after it is submitted.
• You will receive an abstract ID number via email after you have submitted your abstract. Please refer to this abstract number in all correspondence regarding the abstract.
• Please contact us if you have not received confirmation that your abstract has been submitted.
• Please do not submit multiple copies of the same abstract.